Clinical Trial Update: Study of Methylnaltrexone in Opioid-Induced Constipation Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating methylnaltrexone for opioid-induced constipation is being conducted by Chia Tai Tianqing Pharmaceutical Group; the current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Opioid-induced Constipation | Phase 2, Phase 3 | Status: UNKNOWN